Dose Individualization for Phase I Cancer Trials With Broadened Eligibility

Silva, R. B., Cheng, B., Carvajal, R. D., & Lee, S. M. (2024). Dose Individualization for Phase I Cancer Trials With Broadened Eligibility. Statistics in Medicine, 43(29), 5534–5547. Portico. https://doi.org/10.1002/sim.10264
Authors:
Rebecca B Silva
Bin Cheng
Richard D Carvajal
Shing M Lee
Affiliated Authors:
Rebecca B Silva
Bin Cheng
Shing M Lee
Columbia Affiliation:
Subjects:
Clinical Trials, Phase I as Topic (MeSH)
Maximum Tolerated Dose (MeSH)
Neoplasms (MeSH)
Computer Simulation (MeSH)
Dose-Response Relationship, Drug (MeSH)
Author Keywords:
bayesian variable selection
dose selection
patient heterogeneity
phase i
elink
Publication Type:
Article
Unique ID:
10.1002/sim.10264
PMID:
39479896
DOI:
10.1002/sim.10264
Journal:
Statistics in Medicine
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View Web of Science Record
View Scopus Record

Record Created: